Cancer Center Administration

癌症中心管理

• 批准号: 10842468
• 负责人: Sharon Gail Levy
• 金额: $ 234万
• 依托单位: GEORGETOWN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-01-31 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10842468
• 关键词: Academic Medical Centers; Applications Grants; Appointment; Basic Science; Benchmarking; Budgets; Cancer Center; Cancer Center Support Grant; Capital; Clinical; Clinical Cancer Center; Clinical Data; Clinical Protocols; Clinical Research; Clinical Trials; Collaborations; Communication; Community Outreach; Comprehensive Cancer Center; Contracts; Data; Direct Costs; Education and Outreach; Enrollment; Ensure; Environment; Equipment; Evaluation; Faculty; Fostering; Funding; Future; Grant; Guidelines; Health; Human Resources; Individual; Information Systems; Institution; Intervention Trial; Investments; Joints; Knowledge; Leadership; Link; Measurement; Meridians; Methods; Mission; Monitor; National Cancer Institute; New Jersey; Office Management; Peer Review; Policies; Population Research; Process; Productivity; Protocols documentation; Publications; Reporting; Research; Research Infrastructure; Research Personnel; Research Project Grants; Research Support; Resource Sharing; Resources; Safety; Strategic Planning; System; Talents; Training and Education; Translational Research; Universities; Vision; Washington; anticancer research; cancer education; equipment acquisition; experience; meetings; member; operation; peer; programs; recruit; tool

ABSTRACT The mission of the Lombardi Comprehensive Cancer Center (LCCC) Consortium’s Administration is to facilitate and implement LCCC’s vision and create, support and sustain an environment that fosters research, interactivity and optimal productivity of Cancer Center investigators and adds value to the Center. The LCCC Consortium is comprised of Georgetown Lombardi Comprehensive Cancer Center, based in Washington, DC (LCCC-DC) and the John Theurer Cancer Center (JTCC) of Hackensack Meridian Health (HMH), based in Hackensack, NJ (LCCC-NJ). Supporting four Research Programs, nine Shared Resources and 114 members focused on basic, translational, clinical and population-based research, the Administration oversees $13.57M ($11.98M LCCC-DC, $1.58M LCCC-NJ) ADC in peer-reviewed funding and $23.1M ($21.4M LCCC-DC, $1.7M LCCC-NJ) in other grants and contracts (direct costs). Michael Vander Hoek, MHSA, Associate Director (AD) for Administration, heads the administrative team, supporting LCCC leadership planning, strategic investments, benchmarking, evaluation and communication with constituencies. In addition to building an experienced management team to support Cancer Center members, Vander Hoek managed the recruitment of numerous investigators and supported their faculty appointments and promotions. He and his team have successfully managed institutional commitments to support these strategic initiatives. The Administration tracks and manages LCCC’s $216.9M in institutional investments from Georgetown University Medical Center (GUMC), MedStar Health (MH) and HMH, ensuring that investments are linked to LCCC’s strategic plan. The Administration documents and executes LCCC’s policies on membership, pilot funding, equipment purchases, Shared Resources and space. The Administration also coordinates cancer research education and training. Significant expansion of administrative activities has supported an increasingly productive relationship with MH, as a clinical partner, and JTCC, which is LCCC’s clinical campus in New Jersey, aimed at increasing accrual to interventional trials and increasing the diversity of individuals enrolling in trials. For example, the Administration led the implementation of the OnCore enterprise-wide Clinical Trial Management System (CTMS). Other activities are highlighted in the narrative.

抽象的 伦巴第综合癌症中心（LCCC）财团的任务是促进 并实施LCCC的愿景，创造，支持和维护一个促进研究，互动性的环境 癌症中心研究人员的最佳生产力，并为中心增加价值。 LCCC财团是 总部位于华盛顿特区（LCCC-DC）和 Hackensack子午健康（HMH）的John Theurer癌症中心（JTCC），总部位于新泽西州Hackensack （LCCC-NJ）。支持四个研究计划，有9个共享资源和114名专注于基本的成员， 翻译，临床和人群研究，政府监督1,357万美元（1,198万美元LCCC-DC， 158万美元的LCCC-NJ）ADC在同行评审的资金中和2310万美元（2.14亿美元的LCCC-DC，170万美元的LCCC-NJ） 赠款和合同（直接费用）。迈克尔·范德·霍克（Michael Vander Hoek），MHSA，行政管理副总监（广告）， 领导行政团队，支持LCCC领导力计划，战略投资，基准测试， 与选区的评估和沟通。除了建立经验丰富的管理团队 范德·霍克（Vander Hoek）支持癌症中心成员，管理着众多调查员的招聘 支持他们任命和晋升。他和他的团队已成功管理机构 支持这些战略举措的承诺。政府跟踪和管理LCCC的2.169亿美元 乔治敦大学医学中心（GUMC），Medstar Health（MH）和HMH的机构投资， 确保投资与LCCC的战略计划有关。管理文件和执行 LCCC关于会员资格，试点资金，设备购买，共享资源和空间的政策。这 行政管理还协调癌症研究教育和培训。行政的重大扩展 活动支持与MH的临床合作伙伴和JTCC的越来越生产的关系， 是LCCC在新泽西州的临床校园，目的是提高介入试验的准确性并增加 参加试验的个人的多样性。例如，政府领导了OnCore的实施 企业范围内的临床试验管理系统（CTMS）。叙述中强调了其他活动。